Page results
-
This leaflet has written by the administration team at the National Hospital for Neurology and Neurosurgery for outpatients.
-
A UCLH/UCL clinical trial of a personalised therapy for blood cancer has been expanded, meaning new groups of patients with a wider range of blood cancers are now receiving the treatment.
-
This page has been written by the Spasticity Team at the National Hospital for Neurology and Neurosurgery.
-
This page has been written by the Spasticity Team at the National Hospital for Neurology and Neurosurgery for patients (or their family or carers) who have been referred to our service or are under the care of the team at this hospital.
-
A large trial at UCLH and UCL will investigate whether a drug currently in use to treat respiratory conditions can slow the progress of Parkinson’s disease.
-
Fibreoptic Endoscopic Evaluation of Swallow (FEES) patient information leaflet
-
Exhibition co-curated by Healthcare Arts Collective and UCLH Arts and Heritage 25th August - 20th October 2021, UCH Street Gallery, 235 Euston Road
-
The National Day Care Unit provides an opportunity for many people to receive different treatments, tests and procedures without having to stay overnight in the hospital. Some eligible patients who need more than one day of treatment will stay in a hotel near to the hospital.
-
This page provides information on examinations using contrast agents in MRI. It is intended for use by patients (or their families or carers) who have been referred to our service for imaging requiring contrast agents.
-
This page explains what spasticity is. It contains information on botulinum toxin and its use to treat conditions such as spasticity and dystonia which can occur after a stroke or brain injury.
File results
-
FOI/2021/0322 - Incidence and treatment of breast cancer
-
FOI/2021/0326 - International recruitment
-
FOI/2021/0327 - Occupational health physiotheray services
-
FOI/2021/0330 - Sexual assault related incidents
-
FOI/2021/0332 - Trust Policy for Information Governance
-
FOI/2021/0333 - Mental health patient complaints
-
FOI/2021/0339 - Defibrotide for the treatment of hepatic veno-occlusive disease
-
FOI/2021/0341 - Total hospital deaths (all causes)
-
FOI/2021/0343 - Hospital admissions and deaths
-
FOI/2021/0345 - Maternity unit closures